Robotic colorectal surgery using the Senhance® robotic system: a single center experience

Background The aim of this study was to evaluate the initial experience of a single robotic center with the Senhance ® robotic systems (TransEnterix Surgical Inc, Morrisville, NC, USA) in colorectal surgery. Methods We performed a retrospective analysis of prospectively collected data of patients wh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Techniques in coloproctology 2022-06, Vol.26 (6), p.437-442
Hauptverfasser: Samalavicius, N. E., Dulskas, A., Janusonis, V., Klimasauskiene, V., Eismontas, V., Deduchovas, O., Janusonis, T., Markelis, R., Smolskas, E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The aim of this study was to evaluate the initial experience of a single robotic center with the Senhance ® robotic systems (TransEnterix Surgical Inc, Morrisville, NC, USA) in colorectal surgery. Methods We performed a retrospective analysis of prospectively collected data of patients who underwent colorectal surgery using the Senhance ® robotic systems, from November 2018 to November 2020. Perioperative, intraoperative, and short-term postoperative data were assessed. Results There were 57 patients (28 women and 29 men, mean age 61.7 ± 6.2 years [range 23–84 years]). Forty-eight (84.2%) patients underwent surgery for colorectal cancer (22 colon cancer and 26 rectal cancer) and 9 (15.8%) for benign conditions. Mean operating time was 194 min ± 57.8 min (range 90–380 min). In total, 27(47.4%) operations were performed on the colon and 30 (52.6%) on the rectum; mean length of postoperative hospital stay was 8 ± 6.2 days (range 3–48 days). There were 2 (3.4%) conversions to open surgery. No intraoperative complications occurred. Seven patients (12.3%) had postoperative complications 3 (5.3%) of whom had to be treated under general anesthesia. There was no mortality. In 48 patients operated on for colorectal cancer, the mean lymph-node harvest was 18 ± 7.9 (range 7–38 lymph nodes). In the rectal cancer group of 26 patients, the distal resection margin was 3.3 ± 1.8 cm. Conclusions In our experience, surgery using the new Senhance ® robotic system was safe and feasible in surgery of the colon and rectum. Randomized controlled trials comparing this type of colorectal surgery with laparoscopic and/or other types of robotic surgery are needed.
ISSN:1123-6337
1128-045X
DOI:10.1007/s10151-022-02589-x